Cargando…

Effectiveness and safety of low-dose interferon alpha-2a treatment in Behçet’s Syndrome with refractory vascular or neurological involvement: a case series

OBJECTIVE: The aim of this study was to evaluate the effectiveness and safety of low-dose interferon alpha-2a (IFNα2a) in Behçet’s syndrome (BS) patients with refractory vascular/cardiac or neurological involvement. METHODS: In this retrospective cohort study, we consecutively included 25 BS patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Luxi, Hou, Yunxia, Zhang, Lifan, Liu, JinJing, Li, Lu, Wang, Zhimian, Yu, Xin, Zhang, Menghao, Liu, Xiaoqing, Zhao, Yan, Zheng, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340357/ https://www.ncbi.nlm.nih.gov/pubmed/35924012 http://dx.doi.org/10.1177/20406223221111285

Ejemplares similares

Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet’s syndrome: case series and literature review
por: Liu, Jinjing, et al.
Publicado: (2020)

Neutrophil Extracellular Traps Promote Aberrant Macrophages Activation in Behçet’s Disease
por: Li, Lu, et al.
Publicado: (2021)

Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet’s disease
por: Wu, Xiuhua, et al.
Publicado: (2019)

Clinical Features and Risk Factors of Active Tuberculosis in Patients with Behçet's Disease
por: Liu, Yaxu, et al.
Publicado: (2020)

1650. Clinical Features and Risk Factors of Active Tuberculosis in Patients with Behçet’s Disease
por: Liu, Yaxu, et al.
Publicado: (2020)

Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behçet’s uveitis
por: Shi, Jing, et al.
Publicado: (2019)

Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center
por: Sun, Luxi, et al.
Publicado: (2021)

Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet’s disease
por: Zheng, Wenjie, et al.
Publicado: (2022)

Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
por: Lee, Ji Hwan, et al.
Publicado: (2018)

Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behçet’s disease
por: Wu, Xiuhua, et al.
Publicado: (2022)

Correction: Macrophage polarization toward M1 phenotype through NF-κB signaling in patients with Behcet’s disease
por: Wu, Xiuhua, et al.
Publicado: (2022)

Severe panuveitis in neuro-Behçet’s disease in Malaysia: a case series
por: Othman, Khairuddin, et al.
Publicado: (2017)

Behçet oculaire
por: Alami, Ahmed, et al.
Publicado: (2017)

Interferon-α2a treatment for refractory Behçet's disease
por: Lai, Yung Jen, et al.
Publicado: (2018)

Radiological findings in Behçet disease
por: Mohamed, Chraa, et al.
Publicado: (2015)

The Clinical Features, Risk Factors, and Outcome of Aneurysmal Lesions in Behcet's Disease
por: Zhou, Jiaxin, et al.
Publicado: (2019)

Tocilizumab for refractory morphea in adults: A case series
por: Lonowski, Sarah, et al.
Publicado: (2022)

Imaging of the neurological manifestations of dengue: A case series
por: Rangankar, Varsha, et al.
Publicado: (2022)

Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
por: Zhang, Honghong, et al.
Publicado: (2017)

Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study
por: Zhang, Lifan, et al.
Publicado: (2021)

Neurological Manifestations of COVID-19: A Series of Seven Cases
por: Goel, Kavya, et al.
Publicado: (2021)

Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
por: Guney, Esra, et al.
Publicado: (2012)

Outcome of patients with sarcoidosis refractory to TNF antagonists: a case series
por: Thery-Casari, Clémence, et al.
Publicado: (2018)

Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease
por: Park, Ji-Youn, et al.
Publicado: (2015)

Metabolomic alterations associated with Behçet’s disease
por: Zheng, Wenjie, et al.
Publicado: (2018)

Behçet’s Disease and Pregnancy: A Retrospective Case-control Study
por: Barros, Tânia, et al.
Publicado: (2021)

Repository corticotropin injection in patients with refractory psoriatic arthritis: a case series
por: Brown, Alan N
Publicado: (2016)

Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in Children: Case Series and Review of the Literature
por: Doan, Serge, et al.
Publicado: (2016)

A case series: alternative access for refractory shock during cardiac arrest
por: Cui, Charles Q, et al.
Publicado: (2019)

Nonablative radiofrequency in the treatment of refractory vulvar lichen sclerosus: A case series
por: Balbinotti, Rodrigo Rossi, et al.
Publicado: (2021)

Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
por: Levine, Todd
Publicado: (2012)

Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series
por: Lester, Jacobo, et al.
Publicado: (2018)

Orthogonal electrical cardioversion in atrial fibrillation refractory to biphasic shocks: a case series
por: Velázquez-Rodríguez, Enrique, et al.
Publicado: (2020)

Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
por: Xu, Qingqing, et al.
Publicado: (2023)

Neurological Manifestations Associated With SARS-CoV-2 in Children: A Case Series
por: Venceslau, Marianna Tavares, et al.
Publicado: (2022)

Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behçet’s Uveitis: A Randomized Controlled Prospective Study
por: Qian, Yujing, et al.
Publicado: (2021)

Epidemiological, clinical, and therapeutic characteristics of Behçet's disease: a monocentric study in Tunisia
por: Daoud, Fatma, et al.
Publicado: (2021)

Post COVID – 19 neurological disorders; a single center experience; a case series
por: Ahmad, Shwan A., et al.
Publicado: (2022)

Bell’s palsy during interferon alpha 2a treatment in a case with Behçet uveitis
por: Yalçindağ, Fatime Nilüfer, et al.
Publicado: (2013)

Anti-TNF-α agents for refractory intestinal Behçet’s disease: case series and meta-analysis
por: Zhan, Shukai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jfjv13brnmeqcu3436jrkrndqv